53
Attribution: University of Michigan Medical School, Department of Internal Medicine License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/ We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability to use, share, and adapt it. The citation key on the following slide provides information about how you may share and adapt this material. Copyright holders of content included in this material should contact [email protected] with any questions, corrections, or clarification regarding the use of content. For more information about how to cite these materials visit http://open.umich.edu/education/about/terms-of-use. Any medical information in this material is intended to inform and educate and is not a tool for self-diagnosis or a replacement for medical evaluation, advice, diagnosis or treatment by a healthcare professional. Please speak to your physician if you have questions about your medical condition. Viewer discretion is advised: Some medical content is graphic and may not be suitable for all viewers.

09.26.08: Course Introduction

Embed Size (px)

DESCRIPTION

Slideshow is from the University of Michigan Medical School's M2 Renal sequence View additional course materials on Open.Michigan: openmi.ch/med-M2Renal

Citation preview

Page 1: 09.26.08: Course Introduction

Attribution: University of Michigan Medical School, Department of Internal Medicine License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/

We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability to use, share, and adapt it. The citation key on the following slide provides information about how you may share and adapt this material. Copyright holders of content included in this material should contact [email protected] with any questions, corrections, or clarification regarding the use of content. For more information about how to cite these materials visit http://open.umich.edu/education/about/terms-of-use. Any medical information in this material is intended to inform and educate and is not a tool for self-diagnosis or a replacement for medical evaluation, advice, diagnosis or treatment by a healthcare professional. Please speak to your physician if you have questions about your medical condition. Viewer discretion is advised: Some medical content is graphic and may not be suitable for all viewers.

Page 2: 09.26.08: Course Introduction

Citation Key for more information see: http://open.umich.edu/wiki/CitationPolicy

Use + Share + Adapt

Make Your Own Assessment

Creative Commons – Attribution License

Creative Commons – Attribution Share Alike License

Creative Commons – Attribution Noncommercial License

Creative Commons – Attribution Noncommercial Share Alike License

GNU – Free Documentation License

Creative Commons – Zero Waiver

Public Domain – Ineligible: Works that are ineligible for copyright protection in the U.S. (17 USC § 102(b)) *laws in your jurisdiction may differ

Public Domain – Expired: Works that are no longer protected due to an expired copyright term.

Public Domain – Government: Works that are produced by the U.S. Government. (17 USC § 105)

Public Domain – Self Dedicated: Works that a copyright holder has dedicated to the public domain.

Fair Use: Use of works that is determined to be Fair consistent with the U.S. Copyright Act. (17 USC § 107) *laws in your jurisdiction may differ

Our determination DOES NOT mean that all uses of this 3rd-party content are Fair Uses and we DO NOT guarantee that your use of the content is Fair.

To use this content you should do your own independent analysis to determine whether or not your use will be Fair.

{ Content the copyright holder, author, or law permits you to use, share and adapt. }

{ Content Open.Michigan believes can be used, shared, and adapted because it is ineligible for copyright. }

{ Content Open.Michigan has used under a Fair Use determination. }

Page 3: 09.26.08: Course Introduction

RENAL SEQUENCE 9/26 - 10/13

2008

Fall 2008

Page 4: 09.26.08: Course Introduction

Case 1: Tragic Misdiagnosis

25 y.o. female presents complaining of fatigue and mild joint pain. Routine urinalysis with a dipstick shows proteinuria and microscopic hematuria. Diagnosed as cystitis and treated with an antibiotic. 6 months later patient returns with hypertension and edema. Blood tests: Creatinine 10 mg/dl (normal 0.8 - 1.3), BUN 130 mg/dl (normal 10-20), and, on urinalysis, RBC casts. Admitted to hospital and started on dialysis.

Page 5: 09.26.08: Course Introduction

Case 1: Tragic Misdiagnosis

25 y.o. female presents complaining of fatigue and mild joint pain. Routine urinalysis with a dipstick showed proteinuria and microscopic hematuria. Diagnosed as cystitis and treated with an antibiotic. 6 months later patient returns with hypertension and edema. Blood tests: Creatinine 10 mg/dl (normal 0.8 - 1.3), BUN 130 mg/dl (normal 10-20), and, on urinalysis, RBC casts. Admitted to hospital and started on dialysis. Dx: SLE with diffuse proliferative glomerulonephritis

Page 6: 09.26.08: Course Introduction

Case 2: Problems After a Diagnostic Study

75 yo female (45 kg) complaining of intermittent chest pains is admitted to the hospital for cardiac catheterization. Creatinine is 1.7 mg/dl. Following the study, patient is noted to have decreased urine output, and over the next three days her creatinine progressively increases to 5.5.

Page 7: 09.26.08: Course Introduction

Case 2: Problems After a Diagnostic Study

75 yo female (45 kg) complaining of intermittent chest pains is admitted to the hospital for catheterization. Creatinine is 1.7 mg/dl. Following the study, patient is noted to have decreased urine output, and over the next three days her creatinine progressively increases to 5.5. Dx: Contrast-induced acute renal failure in a patient at increased risk because of reduced renal function. Renal function declines with age and at 45 kg she has relatively small muscle mass, lowering creatinine production. The creatinine of 1.7, therefore, represents not a minimally elevated value, but, rather one indicative of substantially decreased baseline glomerular filtration.

Page 8: 09.26.08: Course Introduction

Case 3: Life Threatening Hyperkalemia

A 35 y.o. female with 20 year history of Type I diabetes and hypertension is hospitalized for treatment of a cellulitis. Creatinine - 2.5 mg/dl, K+ 4.8 mEq/L, BP 150/100. The intern starts enalapril (angiotensin converting enzyme inhibitor) and atenolol (beta-blocker). Three days later, BP is well-controlled at 115/70, but morning chemistries return with a K+ is 6.8 and EKG shows peaked T waves and widening of the QRS complex. Urgent treatment for hyperkalemia is started.

Page 9: 09.26.08: Course Introduction

Case 3: Life Threatening Hyperkalemia

A 35 y.o. female with 20 year history of Type I diabetes and hypertension is hospitalized for treatment of a cellulitis. Creatinine - 2.5 mg/dl, K+ 4.8 mEq/L, BP 150/100. The intern starts enalapril (angiotensin converting enzyme inhibitor) and atenolol (beta-blocker). Three days later, BP is well-controlled at 115/70, but morning chemistries return with a K+ is 6.8 and EKG shows peaked T waves and widening of the QRS complex. Urgent treatment for hyperkalemia is started. Dx: Hyperkalemia secondary to inhibition of aldosterone production by angiotensin converting enzyme inhibitor and shift of potassium out of cells by beta-blocker in the setting of preexisting decrease of kidney clearance function and lack of insulin.

Page 10: 09.26.08: Course Introduction

Case 4: A missed treatment opportunity

A 77 y.o. man has a renal scan for assessment of hypertension and a small area of increased tracer uptake is seen in the left upper pole, so he is referred for a CT scan, which shows a small undulation less than 1 cm. in size in the upper left kidney. Repeat CT scan in 6-12 months is recommended but not done. Three years later a repeat CT done to evaluate possible diverticulitis shows a 1.7 cm heterogenously enhancing mass in the posterior left upper kidney and a noncalcified subpleural nodule in the right middle lobe. What is going on?

Page 11: 09.26.08: Course Introduction

Case 4: A missed treatment opportunity

A 77 y.o. man has a renal scan for assessment of hypertension and a small area of increased tracer uptake is seen in the left upper pole, so he is referred for a CT scan, which shows a small undulation less than 1 cm. in size in the upper left kidney. Repeat CT scan in 6-12 months is recommended but not done. Three years later a repeat CT done to evaluate possible diverticulitis shows a 1.7 cm heterogenously enhancing mass in the posterior left upper kidney and a noncalcified subpleural nodule in the right middle lobe. What is going on? Dx: The initial lesion was a renal cell carcinoma (hypernephroma), which grew and metastasized to lung in the subsequent three years, changing a completely curable lesion into one with a much poorer prognosis.

Page 12: 09.26.08: Course Introduction
Page 13: 09.26.08: Course Introduction
Page 14: 09.26.08: Course Introduction
Page 15: 09.26.08: Course Introduction
Page 16: 09.26.08: Course Introduction
Page 17: 09.26.08: Course Introduction

12:00 - 1:00 p.m. Mon. 10/6 Tues. 10/7 Wed. 10/8 Thurs. 10/9 This is a patient contact activity, so please dress appropriately and bring a white coat.

DIALYSIS UNIT VISIT SIGNUP: DATE: ________________ 1. ____________________ 2. ____________________ 3. ____________________ 4. ____________________ 5. ____________________ 6. ____________________ 7._____________________ 8. ____________________

Page 18: 09.26.08: Course Introduction
Page 19: 09.26.08: Course Introduction
Page 20: 09.26.08: Course Introduction
Page 21: 09.26.08: Course Introduction

•  Syllabus - Power Point format used throughout.

•  Web site - CTools M2 page has all Power Point material from the syllabus as Acrobat PDF files and will have updates and additions.

Page 22: 09.26.08: Course Introduction

•  Syllabus - Power Point format used throughout.

•  Web site - CTools M2 page has all Power Point material from the syllabus as Acrobat PDF files and will have updates and additions.

•  Introduction to Pathology, Urinalysis labs, and Electrolyte problems are web-based teaching exercises available via CTools.

Page 23: 09.26.08: Course Introduction
Page 24: 09.26.08: Course Introduction
Page 25: 09.26.08: Course Introduction

•  Syllabus - Power Point format used throughout.

•  Web site - CTools M2 page has all Power Point material from the syllabus as Acrobat PDF files and will have updates and additions.

•  Introduction to Pathology, Urinalysis labs, and Electrolyte problems are web-based teaching exercises available via CTools.

•  Grading Quiz – 10/3-10/5 - Fluid and electrolytes only - 30% Attending and submission of answers to small group problem sets on 10/10 - 5% Laboratory practical - 10/10–10/13 - 10% Written final - 10/10–10/13 - 55%

Page 26: 09.26.08: Course Introduction

Course Texts (not required) !Renal Physiology, 3rd edition by Bruce M. Koeppen and Bruce A. Stanton, Mosby, 2007

Page 27: 09.26.08: Course Introduction

Course Texts (not required) !Renal Physiology, 3rd edition by Bruce M. Koeppen and Bruce A. Stanton, Mosby, 2001 Renal Pathophysiology, The Essentials, 2nd Edition Rennke and Denker, J.B. Lippincott and Co. 2006

Page 28: 09.26.08: Course Introduction

Image of the recommended book for the course: Renal

Pathophysiology, The Essentials, 2nd Edition

Rennke and Denker, J.B. Lippincott and Co. 2006

removed

Page 29: 09.26.08: Course Introduction

Course Texts (not required) !Renal Physiology, 3rd edition by Bruce M. Koeppen and Bruce A. Stanton, Mosby, 2001 Renal Pathophysiology, The Essentials, 2nd Edition Rennke and Denker, J.B. Lippincott and Co. 2006 Robbins 7th edition Primer on Kidney Diseases, 4rd Edition, National Kidney Foundation, 2005

Page 30: 09.26.08: Course Introduction

Kidney Functions !1. Maintenance of body composition - Volume, osmolarity, electrolyte content, and acidity of all body fluids. 2. Excretion and degradation of metabolic end products (e.g. urea), foreign substances (drugs), and hormones (insulin). 3. Production and secretion of enzymes and hormones. - Renin - Erythropoietin - 1,25-Dihydoxyvitamin D3 - Prostanoids

Page 31: 09.26.08: Course Introduction

Source Undetermined

Source Undetermined

Page 32: 09.26.08: Course Introduction

Source Undetermined

Page 33: 09.26.08: Course Introduction

Source Undetermined

Page 34: 09.26.08: Course Introduction

Source Undetermined

Page 35: 09.26.08: Course Introduction

1. Renal pyramid 2. Interlobar artery

3. Renal artery 4. Renal vein

5. Renal hylum 6. Renal pelvis

7. Ureter 8. Minor calyx

9. Renal capsule

10. Inferior renal capsule

11. Superior renal capsule

12. Interlobar vein 13. Nephron

14. Minor calyx 15. Major calyx

16. Renal papilla 17. Renal column

Piotr Michael Jaworski (Wikipedia)

Page 36: 09.26.08: Course Introduction

Gray’s Anatomy

Page 37: 09.26.08: Course Introduction

Source Undetermined

Page 38: 09.26.08: Course Introduction

Source Undetermined

Page 39: 09.26.08: Course Introduction

Faber, Kupin, Krishna, and Narins

Page 40: 09.26.08: Course Introduction

Fig 2-3

Image illustrating the

changes of epithelium along the

nephron removed

Page 41: 09.26.08: Course Introduction

Regents of University of Michigan

Page 42: 09.26.08: Course Introduction

Source Undetermined

Source Undetermined

Page 43: 09.26.08: Course Introduction

Source Undetermined

Page 44: 09.26.08: Course Introduction

Image illustrating similarities

between the epithelial cells of the distal tubule

and collecting duct removed

Figure above showing an epithelial cell of Distal Tubule (similar to collecting tubule

epithelial cell)

Source Undetermined

Page 45: 09.26.08: Course Introduction

Image illustrating the difference between principal cells and

intercalated cells in the collecting duct

removed

Collecting Duct Source Undetermined

Page 46: 09.26.08: Course Introduction

Source Undetermined

Page 47: 09.26.08: Course Introduction

Source Undetermined Source Undetermined

Page 48: 09.26.08: Course Introduction

Source Undetermined

Source Undetermined

Source Undetermined

Page 49: 09.26.08: Course Introduction

Source Undetermined

Source Undetermined

Page 50: 09.26.08: Course Introduction

Patrick Glanz (Wikipedia)

Yassiin Mrabet (Wikipedia)

Page 51: 09.26.08: Course Introduction

Newslighter (Flickr)

Page 52: 09.26.08: Course Introduction

Image illustrating a

kidney surgical procedure removed

Page 53: 09.26.08: Course Introduction

Slide 31: Source Undetermined; Source Undetermined Slide 32: Source Undetermined Slide 33: Source Undetermined Slide 34: Source Undetermined Slide 35: Piotr Michael Jaworski (Wikipedia) http://en.wikipedia.org/wiki/File:KidneyStructures_PioM.svg (Wikipedia), GNU FDL 1.2

http://www.gnu.org/copyleft/fdl.html Slide 36: Gray’s Anatomy Slide 37: Source Undetermined Slide 38: Source Undetermined Slide 39: Faber, Kupin, Krishna, and Narins Slide 41: Regents of University of Michigan, CC: BY-SA-3.0 http://creativecommons.org/licenses/by-sa/3.0/ Slide 42: Source Undetermined; Source Undetermined Slide 43: Source Undetermined Slide 44: Source Undetermined Slide 45: Source Undetermined Slide 46: Source Undetermined Slide 47: Source Undetermined; Source Undetermined Slide 48: Source Undetermined; Source Undetermined; Source Undetermined Slide 49: Source Undetermined; Source Undetermined Slide 50:Yassiin Mrabet (Wikipedia) http://en.wikipedia.org/wiki/File:Hemodialysis-en.svg CC: BY http://creativecommons.org/licenses/by/3.0/ ; Patrick Glanz (Wikipedia) http://en.wikipedia.org/wiki/File:Hemodialysismachine.jpg CC: BY-SA-3.0

http://creativecommons.org/licenses/by-sa/3.0/ Slide 51: Newslighter (Flickr) http://www.flickr.com/photos/newslighter/523392/, CC: BY 2.0 http://creativecommons.org/licenses/by/2.0/deed.en !!! !!!!!!!!!!!!!!!!!!!!!!

!!!!!!!

Additional Source Information for more information see: http://open.umich.edu/wiki/CitationPolicy